Awkward Choreographies from Cancer's Margins: Incommensurabilities of Biographical and Biomedical Knowledge in Sexual and/or Gender Minority Cancer Patients' Treatment

被引:20
作者
Bryson, Mary K. [1 ]
Taylor, Evan T. [2 ]
Boschman, Lorna [2 ]
Hart, Tae L. [3 ]
Gahagan, Jacqueline [4 ]
Rail, Genevieve [5 ]
Ristock, Janice [6 ]
机构
[1] Univ British Columbia, Fac Educ, Dept Language & Literacy Educ, Vancouver, BC, Canada
[2] Univ British Columbia, Dept Language & Literacy Educ, Vancouver, BC, Canada
[3] Ryerson Univ, Dept Psychol, Toronto, ON, Canada
[4] Dalhousie Univ, Sch Hlth & Human Performance, Halifax, NS, Canada
[5] Concordia Univ, Simone de Beauvoir Inst, Montreal, PQ, Canada
[6] Univ Manitoba, Womens & Gender Studies, Winnipeg, MB, Canada
基金
加拿大健康研究院; 芬兰科学院;
关键词
Illness narratives; Biographical knowledge; Choreography; Access to knowledge; Cancer; Sexualities; Genders; LGBT; Transgender; Health disparities; Equity; BREAST-CANCER; TRANSGENDER; HEALTH; GAY; EXPERIENCES; WOMEN; CARE; LESBIANS; SUPPORT; IMPACT;
D O I
10.1007/s10912-018-9542-0
中图分类号
C [社会科学总论];
学科分类号
03 ; 0303 ;
摘要
Canadian and American population-based research concerning sexual and/or gender minority populations provides evidence of persistent breast and gynecologic cancer-related health disparities and knowledge divides. The Cancer's Margins research investigates the complex intersections of sexual and/or gender marginality and incommensurabilities and improvisation in engagements with biographical and biomedical cancer knowledge. The study examines how sexuality and gender are intersectionally constitutive of complex biopolitical mappings of cancer health knowledge that shape knowledge access and its mobilization in health and treatment decision-making. Interviews were conducted with a diverse group (n=81) of sexual and/or gender minority breast or gynecologic cancer patients. The LGBQ//T2 cancer patient narratives we have analyzed document in fine grain detail how it is that sexual and/or gender minority cancer patients punctuate the otherwise lockstep assemblage of their cancer treatment decision-making with a persistent engagement in creative attempts to resist, thwart and otherwise manage the possibility of discrimination and likewise, the probability of institutional erasure in care settings. Our findings illustrate the demands that cancer places on LGBQ//T2 patients to choreograph access to, and mobilization of knowledge and care, across significantly distinct and sometimes incommensurable systems of knowledge.
引用
收藏
页码:341 / 361
页数:21
相关论文
共 45 条
  • [41] The association of delay in curative intent treatment with survival among breast cancer patients: findings from the Women's Health Initiative
    Yung, Rachel
    Ray, Roberta M.
    Roth, Joshua
    Johnson, Lisa
    Warnick, Greg
    Anderson, Garnet L.
    Kroenke, Candyce H.
    Chlebowski, Rowan T.
    Simon, Michael S.
    Fung, Chunkit
    Pan, Kathy
    Wang, Di
    Barrington, Wendy E.
    Reding, Kerryn W.
    BREAST CANCER RESEARCH AND TREATMENT, 2020, 180 (03) : 747 - 757
  • [42] Cervicovaginal-Microbiome Analysis by 16S Sequencing and Real-Time PCR in Patients from Novosibirsk (Russia) with Cervical Lesions and Several Years after Cancer Treatment
    Ivanov, Mikhail K.
    Brenner, Evgeny V.
    Hodkevich, Anastasia A.
    Dzyubenko, Victoria V.
    Krasilnikov, Sergey E.
    Mansurova, Alphiya S.
    Vakhturova, Irina E.
    Agletdinov, Eduard F.
    Shumeikina, Anastasia O.
    Chernyshova, Alyona L.
    Titov, Sergei E.
    DIAGNOSTICS, 2023, 13 (01)
  • [43] Trastuzumab emtansine versus treatment of physician's choice in patients with previously treated HER2-positive metastatic breast cancer (TH3RESA): final overall survival results from a randomised open-label phase 3 trial
    Krop, Ian E.
    Kim, Sung-Bae
    Gonzalez Martin, Antonio
    LoRusso, Patricia M.
    Ferrero, Jean-Marc
    Badovinac-Crnjevic, Tanja
    Hoersch, Silke
    Smitt, Melanie
    Wildiers, Hans
    LANCET ONCOLOGY, 2017, 18 (06) : 743 - 754
  • [44] Trastuzumab deruxtecan for the treatment of patients with HER2-positive breast cancer with brain and/or leptomeningeal metastases: an updated overall survival analysis using data from a multicenter retrospective study (ROSET-BM) (Aug, 10.1007/s12282-024-01614-1, 2024)
    Nakayama, Takahiro
    Niikura, Naoki
    Yamanaka, Takashi
    Yamamoto, Mitsugu
    Matsuura, Kazuo
    Inoue, Kenichi
    Takahara, Sachiko
    Nomura, Hironori
    Kita, Shosuke
    Yamaguchi, Miki
    Aruga, Tomoyuki
    Shibata, Nobuhiro
    Shimomura, Akihiko
    Ozaki, Yuri
    Sakai, Shuji
    Takiguchi, Daisuke
    Takata, Takehiko
    Bastanfard, Armin
    Shiosakai, Kazuhito
    Tsurutani, Junji
    BREAST CANCER, 2024, 31 (06) : 1184 - 1184
  • [45] Psychoanalytisch-orientierte Fokaltherapie der Depression bei KrebskrankenBehandlungsmanual auf der Grundlage der supportiv-expressiven Psychotherapie nach LuborskyPsychodynamic short-term therapy for cancer patients suffering from depressionA treatment manual on the basis of Luborsky’s supportive-expressive therapy
    Antje Haselbacher
    Yvette Barthel
    Elmar Brähler
    Barbara Imruck
    Susanne Kuhnt
    Rüdiger Zwerenz
    Manfred. E. Beutel
    Psychotherapeut, 2010, 55 (4): : 321 - 328